These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6709052)

  • 1. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.
    Morein B; Sundquist B; Höglund S; Dalsgaard K; Osterhaus A
    Nature; 1984 Mar 29-Apr 4; 308(5958):457-60. PubMed ID: 6709052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza virus ISCOMs: biochemical characterization.
    Sundquist B; Lövgren K; Höglund S; Morein B
    Vaccine; 1988 Feb; 6(1):44-8. PubMed ID: 3354257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the immune response by immunization with antigens in defined multimeric physical forms.
    Morein B
    Vet Immunol Immunopathol; 1987 Dec; 17(1-4):153-9. PubMed ID: 3124333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes.
    Morein B; Simons K
    Vaccine; 1985 Jun; 3(2):83-93. PubMed ID: 3898625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation of polymeric glycoprotein complexes of enveloped viruses using the Quill A glycoside and a study of their immunogenic activity].
    Berezin VE; Zaĭdes VE; Grigor'ev VB; Klimenko SM; Zhdanov VM
    Vopr Virusol; 1987; 32(3):312-7. PubMed ID: 2823481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations.
    Behboudi S; Morein B; Villacres-Eriksson M
    Cytokine; 1997 Sep; 9(9):682-7. PubMed ID: 9325017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Quil A on liposomal membranes.
    Paepenmüller T; Müller-Goymann CC
    Int J Pharm; 2014 Nov; 475(1-2):138-46. PubMed ID: 25107288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
    Rönnberg B; Fekadu M; Morein B
    Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
    Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
    Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
    Behboudi S; Morein B; Rönnberg B
    Vaccine; 1995 Dec; 13(17):1690-6. PubMed ID: 8719521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice.
    de Vries P; van Binnendijk RS; van der Marel P; van Wezel AL; Voorma HO; Sundquist B; Uytdehaag FG; Osterhaus AD
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():549-59. PubMed ID: 3258355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
    Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
    Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
    Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier.
    Lövgren K; Lindmark J; Pipkorn R; Morein B
    J Immunol Methods; 1987 Apr; 98(1):137-43. PubMed ID: 2435808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.
    Fossum C; Bergström M; Lövgren K; Watson DL; Morein B
    Cell Immunol; 1990 Sep; 129(2):414-25. PubMed ID: 2383899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids.
    Behboudi S; Morein B; Villacres-Eriksson M
    Clin Exp Immunol; 1996 Jul; 105(1):26-30. PubMed ID: 8697631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine leukaemia virus ISCOMs: biochemical characterization.
    Merza MS; Linné T; Höglund S; Portetelle D; Burny A; Morein B
    Vaccine; 1989 Feb; 7(1):22-8. PubMed ID: 2541575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quaternary structure of the immunostimulating complex (iscom).
    Ozel M; Höglund S; Gelderblom HR; Morein B
    J Ultrastruct Mol Struct Res; 1989 Dec; 102(3):240-8. PubMed ID: 2634709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response.
    Villacres-Eriksson M; Behboudi S; Morgan AJ; Trinchieri G; Morein B
    Cytokine; 1997 Feb; 9(2):73-82. PubMed ID: 9071557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes.
    Villacres-Eriksson M
    Clin Exp Immunol; 1995 Oct; 102(1):46-52. PubMed ID: 7554398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.